Cargando…
Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III
Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the ASFV has been proven to be a serotype-specific pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221915/ https://www.ncbi.nlm.nih.gov/pubmed/37243111 http://dx.doi.org/10.3390/vaccines11051007 |
_version_ | 1785049570759147520 |
---|---|
author | Sereda, Alexey D. Kazakova, Anna S. Namsrayn, Sanzhi G. Vlasov, Mikhail E. Sindryakova, Irina P. Kolbasov, Denis V. |
author_facet | Sereda, Alexey D. Kazakova, Anna S. Namsrayn, Sanzhi G. Vlasov, Mikhail E. Sindryakova, Irina P. Kolbasov, Denis V. |
author_sort | Sereda, Alexey D. |
collection | PubMed |
description | Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the ASFV has been proven to be a serotype-specific protein. Current work is devoted to the investigation of the possibility of creating protection against virulent ASFV strain Mozambique-78 (seroimmunotype III) in pigs previously vaccinated with vaccine strain FK-32/135 (seroimmunotype IV) and then immunized with the pUBB76A_CD2v plasmid, containing a chimeric nucleotide sequence from the CD2v protein gene (EP402R, nucleotides from 49 to 651) from the MK-200 strain (seroimmunotype III). Vaccination with the ASFV vaccine strain FK-32/135 protects pigs from the disease caused by the strain with homologous seroimmunotype—France-32 (seroimmunotype IV). Our attempt to create balanced protection against virulent strain Mozambique-78 (seroimmunotype III) by induction of both humoral factors of immunity (by vaccination with strain FK-32/135 of seroimmunotype IV) and serotype-specific cellular immunity (by immunization with the plasmid pUBB76A_CD2v of seroimmunotype III) was unsuccessful. |
format | Online Article Text |
id | pubmed-10221915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102219152023-05-28 Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III Sereda, Alexey D. Kazakova, Anna S. Namsrayn, Sanzhi G. Vlasov, Mikhail E. Sindryakova, Irina P. Kolbasov, Denis V. Vaccines (Basel) Article Understanding the immunological mechanisms of protection and the viral proteins involved in the induction of a protective immune response to the African swine fever virus (ASFV) is still limited. In the last years, the CD2v protein (gp110-140) of the ASFV has been proven to be a serotype-specific protein. Current work is devoted to the investigation of the possibility of creating protection against virulent ASFV strain Mozambique-78 (seroimmunotype III) in pigs previously vaccinated with vaccine strain FK-32/135 (seroimmunotype IV) and then immunized with the pUBB76A_CD2v plasmid, containing a chimeric nucleotide sequence from the CD2v protein gene (EP402R, nucleotides from 49 to 651) from the MK-200 strain (seroimmunotype III). Vaccination with the ASFV vaccine strain FK-32/135 protects pigs from the disease caused by the strain with homologous seroimmunotype—France-32 (seroimmunotype IV). Our attempt to create balanced protection against virulent strain Mozambique-78 (seroimmunotype III) by induction of both humoral factors of immunity (by vaccination with strain FK-32/135 of seroimmunotype IV) and serotype-specific cellular immunity (by immunization with the plasmid pUBB76A_CD2v of seroimmunotype III) was unsuccessful. MDPI 2023-05-21 /pmc/articles/PMC10221915/ /pubmed/37243111 http://dx.doi.org/10.3390/vaccines11051007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sereda, Alexey D. Kazakova, Anna S. Namsrayn, Sanzhi G. Vlasov, Mikhail E. Sindryakova, Irina P. Kolbasov, Denis V. Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III |
title | Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III |
title_full | Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III |
title_fullStr | Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III |
title_full_unstemmed | Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III |
title_short | Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III |
title_sort | subsequent immunization of pigs with african swine fever virus (asfv) seroimmunotype iv vaccine strain fk-32/135 and by recombinant plasmid dna containing the cd2v derived from mk-200 asfv seroimmunotype iii strain does not protect from challenge with asfv seroimmunotype iii |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221915/ https://www.ncbi.nlm.nih.gov/pubmed/37243111 http://dx.doi.org/10.3390/vaccines11051007 |
work_keys_str_mv | AT seredaalexeyd subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii AT kazakovaannas subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii AT namsraynsanzhig subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii AT vlasovmikhaile subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii AT sindryakovairinap subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii AT kolbasovdenisv subsequentimmunizationofpigswithafricanswinefevervirusasfvseroimmunotypeivvaccinestrainfk32135andbyrecombinantplasmiddnacontainingthecd2vderivedfrommk200asfvseroimmunotypeiiistraindoesnotprotectfromchallengewithasfvseroimmunotypeiii |